BIO-key International, Inc. (OTCMKTS:BKYI) Surges After Quarterly Results

[[tagnumber 0]][[tagnumber 1]]BIO–key International, Inc. (OTCMKTS:BKYI)’s stock is usually being traded in very low volumes and the daily percentile movements that it makes are very small. The overall performance since the beginning of the year has not been very good, but we might see things change.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]This time of the year we get to see how the companies have fared in the first quarter. [[tagnumber 6]]BKYI [[tagnumber 7]]also filed its financial report in Thursday last week. It contained the following numbers in the balance sheet.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $303 thousand[[tagnumber 13]] [[tagnumber 12]]current assets: $1.2 million[[tagnumber 13]] [[tagnumber 12]]current liabilities: $1.49 million[[tagnumber 13]] [[tagnumber 12]]quarterly revenues: $648 thousand[[tagnumber 13]] [[tagnumber 12]]quarterly net loss: $924 thousand[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Those numbers aren’t exactly bad for an OTC company. On the downside, we see that the revenues have dropped compared to the same period last year. As we were assured by a press release from May 13, however, is due to less in licensing fees. The revenue coming from services has stayed almost the same.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]In that press release we were also informed that the revenue guidance for 2015 remains in the ranges from $5 million to $7 million, which is more than that of 2014. This will not be surprising, considering the fact that although we saw the revenues drop in the final months of last year, the company recorded more than double the revenue posted in 2013.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Overall, despite the fact that [[tagnumber 6]]BKYI [[tagnumber 7]]is still unable to operate at a profit it is a pretty decent company compared to others we see in the OTC markets. Investors were probably a bit slow to react on the press release and the quarterly report because after going nowhere in Monday we saw [[tagnumber 6]]BKYI [[tagnumber 7]]jump 17.86% in yesterday’s session on nearly 10 times its average volume.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Still, we see [[tagnumber 6]]BKYI [[tagnumber 7]]hesitating since today’s market open, so be sure to do your due diligence and weigh out the risks before putting any money on the line.[[tagnumber 2]]